Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Rhode Island

Phase 1 cancer trials in Rhode Island

20 Phase 1 cancer studies are recruiting participants at sites in 2 cities across Rhode Island as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Rhode Island city with a recruiting study

By research area: Lung Cancer (6), Lymphoma (6), Prostate Cancer (5), Breast Cancer (3).

Providence (19), East Providence (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Rhode Island

Basic details from each study's public record (the 12 most recently updated of 20). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Recruiting in
    Providence
    Registry record
    NCT05579366 · updated
  2. Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Providence
    Registry record
    NCT06084481 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Rhode Island on ClinicalTrials.gov.

Lung cancer: recently updated in Rhode Island

  1. A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Providence
    Registry record
    NCT06996782 · updated
  2. Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bicara Therapeutics
    Recruiting in
    Providence
    Registry record
    NCT04429542 · updated
  3. Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Recruiting in
    Providence
    Registry record
    NCT05797168 · updated
  4. Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Recruiting in
    East Providence
    Registry record
    NCT06750185 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Rhode Island on ClinicalTrials.gov.

Prostate cancer: recently updated in Rhode Island

  1. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Regeneron Pharmaceuticals
    Recruiting in
    Providence
    Registry record
    NCT03972657 · updated
  2. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    Janux Therapeutics
    Recruiting in
    Providence
    Registry record
    NCT05519449 · updated
  3. Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    • Phase 1/2
    • Ages 18 to 130
    • Male participants
    Sponsor
    AstraZeneca
    Recruiting in
    Providence
    Registry record
    NCT07181161 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Rhode Island on ClinicalTrials.gov.

Ask about studies in Rhode Island

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call